NUTX
Nutex Health Inc
201.90$
-3.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -17.0% | +1.5% | +4.5% | +3.8% | +49.4% | +16.3% | +10.4% | +14.7% | -4.8% | +4.2% | +0.8% | |
| – | +1.1% | +10.5% | +13.5% | +5.2% | +144.1% | +37.3% | +17.8% | +25.3% | -9.1% | +7.6% | +1.0% | |
| – | -18.0% | +36.4% | +36.0% | +15.0% | -7.1% | +94.4% | +14.2% | +71.7% | +11.8% | +11.7% | -1.0% | |
| – | -18.0% | +36.4% | +36.0% | +15.0% | -7.1% | +94.4% | – | – | +11.8% | +11.7% | -1.0% | |
| – | +14.8% | +4.7% | -0.8% | +96,082.0% | -99.6% | +26.8% | +18.6% | +9.1% | -16.0% | +4.3% | +5.0% | |
| – | +26.4% | -12.2% | -7.3% | -18.1% | +26.1% | +9.4% | -27.0% | +38.8% | -9.2% | +63.3% | -10.1% | |
| – | -4.8% | +0.0% | -18.4% | +99,900.0% | -99.9% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -5.1% | -2.0% | -19.5% | -2.0% | -2.1% | -2.1% | -2.1% | +44.9% | -1.5% | -1.5% | -1.6% | |
| – | -14.8% | +1.6% | +5.0% | +5.4% | +26.4% | +7.4% | +3.5% | +4.4% | -6.0% | +4.1% | -11.2% | |
| – | -13.3% | +2.7% | +19.7% | -5.7% | +108.5% | +25.3% | +10.4% | -4.8% | -14.9% | +16.8% | -36.4% | |
| – | -30.2% | -9.7% | +36.3% | +72,045.9% | -99.8% | +11.4% | – | – | -28.4% | +13.3% | -31.5% | |
| – | +43.3% | -4.8% | -2.2% | -56.2% | +35.2% | +82.8% | +17.8% | +64.9% | -1.2% | +2.9% | -80.2% | |
| – | +36.3% | 0.0% | -14.8% | +19.6% | -16.2% | -3.3% | -5.8% | +25.0% | +14.1% | -16.8% | +28.2% | |
| – | -31.7% | +2.5% | -0.5% | +27.2% | +83.4% | +34.7% | +19.4% | +34.8% | +3.9% | +5.1% | +13.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4.9% | +9.0% | +8.3% | +49.9% | -31.6% | +14.8% | +12.7% | +8.8% | +0.0% | +0.0% | -2.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.